Reversible ligand binding to human serum albumin. Theoretical and clinical aspects

Danish Medical Bulletin

Volumn 46, Issue 5, 1999, Pages 379-399

  Vorum, Henrik ^a,b  

^a AARHUS UNIVERSITY   (Denmark)

^b NONE   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; FATTY ACID; SERUM ALBUMIN;

AMINO ACID SEQUENCE; BINDING AFFINITY; CONFORMATION; HUMAN; LIGAND BINDING; PROTEIN ANALYSIS; PROTEIN STRUCTURE; REVIEW; SOLUBILITY; STRUCTURE ACTIVITY RELATION;

AMINO ACID SEQUENCE; ANIMALS; BINDING SITES; HUMANS; KINETICS; LIGANDS; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; SERUM ALBUMIN;

EID: 0032760203     PISSN: 09078916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (205)

1. Vorum, H., Andersen, S., and Brodersen, R. Valproate competes with palmitate for binding to serum albumin. Epilepsia 30, 370-373, 1989.
2. Brodersen, R., Vorum, H., Skriver, E., and Pedersen, A.O. Serum albumin binding of palmitate and stearate - Multiple binding theory for insoluble ligands. Eur. J. Biochem. 182, 19-25, 1989.
3. Brodersen, R., Jørgensen, N., Vorum, H., and Krukow, N. Valproate and palmitate binding to human serum albumin: An hypothesis on obesity. Mol. Pharmacol. 37, 704-709, 1990.
4. Vorum, H., Brodersen, R., Kragh-Hansen, U., and Pedersen, A.O. Solubility of fatty acids in phosphate buffer at pH 7.4. Biochim. Biophys. Acta. 1126, 135-142, 1992.
5. Vorum, H., Pedersen, A.O., and Honoré, B. Fatty acid and drug binding to a low-affinity component of human serum albumin, purified by affinity chromatography. Int. J. Peptide Protein Res. 40, 415-422, 1992.
6. Vorum, H., Bang, D., and Fisker, K. New procedure for analysing drug binding data - Exemplified by warfarin binding to human serum albumin. Biochem. Pharmacol. 45, 1715-1720, 1993.
7. Vorum, H., Jørgensen, H.R.I., and Brodersen, R. Variation in the binding affinity of warfarin and phenprocoumon to human serum albumin in relation to surgery. Eur. J. Clin. Pharmacol. 44, 157-162, 1993.
8. Vorum, H., Gram, L., and Honoré, B. Valproate and palmitate binding to serum albumin in valproate-treated patíents. Relation to obesity. Epilepsy Res. 16, 55-64, 1993.
9. Kragh-Hansen, U. and Vorum, H. Quantitative analyses of the interaction between calcium ions and human serum albumin. Clin. Chem. 39, 202-208, 1993.
10. Vorum, H., Fisker, K., and Brodersen, R. High-affinity of two molecules of warfarin and phenprocoumon to human serum albumin. Biochim. Biophys. Acta. 1205, 178-182, 1994.
11. Brodersen, R., Vorum, H., and Andersen, S. Measurement of palmitate availability in serum samples - Method and utility. Chem. Phys. Lipids. 71, 13-20, 1994.
12. Vorum, H. and Brodersen, R. Adsorption and physical state of medium- and long-chain fatty acids in neutral aqueous buffer solution. Chem. Phys. Lipids. 74, 43-48, 1994.
13. Vorum, H., Fisker, K., Otagiri, M., Pedersen, A.O., and Kragh-Hansen, U. Calcium ion binding to clinical relevant chemical modifications of human serum albumin. Clin. Chem. 41, 1654-1661, 1995.
14. Vorum, H., and Honoré, B. Influence of fatty acids on the binding of warfarin and phenprocoumon to human serum albumin with relation to anticoagulant therapy. J. Pharm. Pharmacol. 48, 870-875, 1996.
15. Vorum, H., Fisker, K., and Honoré, B. Plamitate and stearate binding to human serum albumin. Determination of relative binding constants. J. Peptide Res. 49, 347-354, 1997.
16. Adair, G. S. 1925. The Hemoglobin System - VI. The Oxygen Dissociation Curve of Hemoglobin. J. Biol. Chem. 63: 529-545.
17. Adams, P. A. and M. C. Berman. 1980. Kinetics and mechanism of the interaction between human serum albumin and monomeric haemin. Biochem. J. 191: 95-102.
18. Aguanno, J. J. and J. H. Ladenson. 1982. Influence of fatty acids on the binding of calcium to human albumin. Correlation of binding and conformation studies and evidence for distinct differences between unsaturated fatty acids and saturated fatty acids. J. Biol. Chem. 257: 8745-8748.
19. Aki, H. and M. Yamamoto. 1989. Thermodynamics of the binding of phenothiazines to human plasma, human serum albumin and alpha 1-acid glycoprotein: a calorimetric study. J. Pharm. Pharmacol. 41: 674-679.
20. Aki, H. and M. Yamamoto. 1992. Thermodynamic aspects of fatty acids binding to human serum albumin: a microcalorimetric investigation. Chem. Pharm. Bull. Tokyo. 40: 1553-1558.
21. Ashbrook, J. D., A. A. Spector, and J. E. Fletcher. 1972. Medium Chain Fatty Acid Binding to Human Plasma Albumin. J. Biol. Chem. 247: 7038-7042.
22. Ashbrook, J. D., A. A. Spector, E. C. Santos, and J. E. Fletcher. 1975. Long chain fatty acid binding to human plasma albumin. J. Biol. Chem. 250: 2333-2338.
23. Babu, Y. S., C. E. Bugg, and W. J. Cook. 1988. Structure of calmodulin refined at 2.2 Å resolution. J. Mol. Biol. 204: 191-204.
24. Beaven, G. H., S. H. Chen, A. Albis, and W. B. Gratzer. 1974. A spectroscopic study of the haemin-human-serum-albumin system. Eur. J. Biochem. 41: 539-546.
25. Bennhold, H. 1997. Das Menschliche Serumalbumin. Bull. Schweiz Akad. Med. Wissenchr. 17: 62-76.
26. Blauer, G., D. Harmatz, and A. Naparstek. 1970. Circular Dichroism of Bilibrubin-Human Serum Albumin Complexes in Aqueous Solution. FEBS Lett. 9: 53-55.
27. Bojesen, I. N. and E. Bojesen. 1992. Water-phase palmitate concentrations in equilibrium with albumin-bound palmitate in a biological system. J. Lipid. Res. 33: 1327-1334.
28. Bojesen, I. N. and E. Bojesen. 1994. Binding of arachidonate and oleate to bovine serum albumin. J. Lipid. Res. 35: 770-778.
29. Bos, O. J., M. J. Fischer, J. Wilting, and L. H. Janssen. 1989. Mechanism by which warfarin binds to human serum albumin. Stopped-flow kinetic experiments with two large fragments of albumin. Biochem. Pharmacol. 38: 1979-1984.
30. Bos, O. J., J. F. Labro, M. J. Fischer, J. Wilting, and L. H. Janssen. 1989. The molecular mechanism of the neutral-to-base transition of human serum albumin. Acid/base titration and proton nuclear magnetic resonance studies on a large peptic and a large tryptic fragment of albumin. J. Biol. Chem. 264: 953-959.
31. Bos, O. J., J. P. Remijn, M. J. Fischer, J. Wilting, and L. H. Janssen. 1988. Location and characterization of the warfarin binding site of human serum albumin. A comparative study of two large fragments. Biochem. Pharmacol. 37: 3905-3909.
32. Brodersen, R. 1979. Binding of Bilirubin to Albumin - Implications for Prevention of Bilirubin Encephalopathy in the Newnborn. In Reviews in Clinical Laboratory Sciences. CRC Press, Inc., 305-399.
33. Brodersen, R. 1980. Binding of bilirubin to albumin. CRC. Crit. Rev. Clin. Lab. Sci. 11: 305-399.
34. Brodersen, R., S. Andersen, C. Jacobsen, O. Sonderskov, F. Ebbesen, W. J. Cashore, and S. Larsen. 1982. Determination of reserve albumin-equivalent for ligand binding, probing two distinct binding functions of the protein. Anal. Biochem. 121: 395-408.
35. Brodersen, R., S. Andersen, H. Vorum, S. U. Nielsen, and A. O. Pedersen. 1990. Multiple fatty acid binding to albumin in human blood plasma. Eur. J. Biochem. 189: 343-349.
36. Brodersen, R., B. Honoré, and S. Andersen. 1988. Palmitate binding to serum albumin, measured by rate of dialysis. Eur. J. Biochem. 174: 45-50.
37. Brodersen, R., B. Honoré, A. O. Pedersen, and I. M. Klotz. 1988. Binding constants for ligand-carrier complexes. Trends. Pharmacol. Sci. 9: 252-257.
38. Brodersen, R., A. Knudsen, and A. O. Pedersen. 1987. Cobinding of bilirubin and sulfonamide and of two bilirubin molecules to human serum albumin: a site model. Arch. Biochem. Biophys. 252: 561-569.
39. Brodersen, R., F. Nielsen, J. C. Christiansen, and K. Andersen. 1987. Characterization of binding equilibrium data by a variety of fitted isotherms. Eur. J. Biochem. 169: 487-495.
40. Brodersen, R., H. Vorum, N. Krukow, and A. O. Pedersen. 1991. Binding of long-chain fatty acids to serum albumin in healthy humans. Relationship to obesity. Eur. J. Biochem. 197: 461-465.
41. Brodersen, R., H. Vorum, and A.O. Pedersen. 1990. In Plasma Binding of Drugs and its Consequences. F. Belpaire, M. Bogaert, J.P. Tillement, and R. Verbeeck, editors. Academic Press, Ghent. 31-42.
42. Brown, J. R. 1974. Structure of serum albumin: Disulfide bridges. Fed. Proc. 1389-1390.
43. Brown, J.R. and P. Shockley. 1982. Serum Albumin: Structure and Caracterization of Its Ligand Binding Sites. In Lipid-Protein Interactions. P.A. Jost and O.H. Griffith, editors. Wiley & Sons, New York. 25-68.
44. Brown, N. A. and W. E. Muller. 1978. Binding of coumarin anticoagulants to human and bovine serum albumin. Circular dichroism studies. Pharmacology 17: 233-238.
45. Bull, T. E., B. Halle, and B. Lindman. 1978. Internal motion at the chloride binding sites of human serum albumin by NMR relaxation studies. FEBS Lett. 86: 25-28.
46. Burczynski, F. J., S. M. Pond, C. K. Davis, L. P. Johnson, and R. A. Weisiger. 1993. Calibration of albumin-fatty acid binding constants measured by heptane-water partition. Am. J. Physiol. 265: G555-G563.
47. Campillo, J. E., A. S. Luyckx, M. D. Torres, and P. J. Lefebvre. 1979. Effect of oleic acid on insulin secretion by the isolated perfused rat pancreas. Diabetologia. 16: 267-273.
48. Carter, D. A. and J. X. Ho. 1994. Structure of Serum Albumin. Adv. Protein Chem. 45: 153-203.
49. Chakrabarti, S., R. Laliberte, and J. Brodeur. 1976. Influence of long-chain free fatty acids on the binding of warfarin to bovine serum albumin. Biochem. Pharmacol. 25: 2515-2521.
50. Chakrabarti, S. K. 1978. Cooperativity of warfarin binding with human serum albumin induced by free fatty acid anion. Biochem. Pharmacol. 27: 739-743.
51. Chignell, C. F. and D. K. Starkweather. 1971. Optical studies of drugprotein complexes. V. The interaction of phenylbutazone, flufenamic acid, and dicoumarol with acetylsalicylic acid-treated human serum albumin. Mol. Pharmacol. 7: 229-237.
52. Cistola, D. P., D. Atkinson, J. A. Hamilton, and D. M. Small. 1986. Phase behavior and bilayer properties of fatty acids: hydrated 1: 1 acid-soaps. Biochemistry. 25: 2804-2812.
53. Cistola, D. P., J. A. Hamilton, D. Jackson, and D. M. Small. 1988. lonization and phase behavior of fatty acids in water: application of the Gibbs phase rule. Biochemistry. 27: 1881-1888.
54. Cistola, D. P., D. M. Small, and J. A. Hamilton. 1987. Carbon 13 NMR studies of saturated fatty acids bound to bovine serum albumin. I. The filling of individual fatty acid binding sites. J. Biol. Chem. 262: 10971-10979.
55. Cistola, D. P., D. M. Small, and J. A. Hamilton. 1987. Carbon 13 NMR studies of saturated fatty acids bound to bovine serum albumin. II. Electrostatic interactions in individual fatty acid binding sites. J. Biol. Chem. 262: 10980-10985.
56. Diana, F. J., K. Veronich, and A. L. Kapoor. 1989. Binding of nonsteroidal anti-inflammatory agents and their effect on binding of racemic warfarin and its enantiomers to human serum albumin. J. Pharm. Sci. 78: 195-199.
57. Dinesen, H., L. Gram, T. Andersen, and M. Dam. 1984. Weight gain during treatment with valproate. Acta Neurol. Scand. 70: 65-69.
58. Eagland, D. and F. Franks. 1965. Association Equilibria in Dilute Aqueous Solutions of Carboxylic Acid Soaps. Trans. Faraday Soc. 61: 2468-2477.
59. Eggenberger, D. N., F. K. Broome, A. W. Ralston, and H. J. Harwood. 1949. The Solubilities of the Normal Saturated Fatty Acids in Water. J. Org. Chem. 14: 1108-1110.
60. Egger, J. and E. M. Brett. 1981. Effects of sodium valproate in 100 children with special reference to weight. Br. Med. J. Clin. Res. Ed. 283: 577-581.
61. Fehske, K. J., U. Schlafer, U. Wollert, and W. E. Muller. 1982. Characterization of an important drug binding area on human serum albumin including the high-affinity binding sites of warfarin and azapropazone. Mol. Pharmacol. 21: 387-393.
62. Fleitman, J. S., J. Bruni, J. H. Perrin, and B. J. Wilder. 1980. Albumin-binding interactions of sodium valproate. J. Clin. Pharmacol. 20: 514-517.
63. Fletcher, J. E., J. D. Ashbrook, and A. A. Spector. 1973. Computer analysis of drug-protein binding data. Ann. N. Y. Acad. Sci. 226: 69-81.
64. Fletcher, J. E., A. A. Spector, and J. D. Ashbrook. 1970. Analysis of macromolecule-ligand binding by determination of stepwise equilibrium constants. Biochemistry. 9: 4580-4587.
65. Fogh-Andersen, N. 1977. Albumin/calcium association at different pH, as determined by potentiometry. Clin. Chem. 23: 2122-2126.
66. Foster, J.F. 1960. Plasma albumin. In The plasma proteins. F. W. Putnam, editor. Academic Press, New York. 179-239.
67. Foster, J. F. 1977. Some Aspects of The Structure and Conformational Properties of Serum Albumin. In Albumin Structure, Function and Uses. V.M. Rosenoer, M. Oratz, and M.A. Rothschild, editors. Pergamon Press, New York. 53-84.
68. Frye, R. M., H. Lees, and G. A. Rechnitz. 1974. Magnesium-albumin binding measurements using ion-selective membrane electrodes. Clin. Biochem. 7: 258-270.
69. Garten, S. and W. D. Wosilait. 1972. An analysis of the binding of coumarin anticoagulants by human serum albumin. Comp. Gen. Pharmacol. 3: 83-88.
70. Gitzelmann-Cumarasamy, N., R. Gitzelmann, K. J. Wilson, and C. C. Kuenzle. 1979. Fetal and adult albumins are indistinguishable by immunological and physicochemical criteria. Proc. Natl. Acad. Sci. U.S.A. 76: 2960-2963.
71. Glennon, J. D. and B. Sarkar. 1982. Nickel (II) transport in human blood plasma. Studies of nickel (II) binding to human albumin and to native-sequence peptide, and ternary-complex formation with L-histidine. Biochem. J. 203: 15-23.
72. Goodman, D. S. 1958. The Distribution of Fatty Acids between n-Heptane and Aqueous Phosphate Buffer. J. Am. Chem. Soc. 80: 3887-3892.
73. Goodman, D. S. 1958. The Interaction of Human Serum Albumin with Long-Chain Fatty Acid Anions. J. Am. Chem. Soc. 80: 3892-3898.
74. Gram, L. 1990. Valproate. In Comprehensive Epileptology. M. Dam and L. Gram, editors. Raven Press, New York, NY. 537-546.
75. Halle, B. and B. Lindman. 1978. Chloride ion binding to human plasma albumin from chlorine-35 quadrupole relaxation. Biochemistry. 17: 3774-3781.
76. Hamilton, J. A., S. Era, S. P. Bhamidipati, and R. G. Reed. 1991. Locations of the three primary binding sites for long-chain fatty acids on bovine serum albumin. Proc. Natl. Acad. Sci. U. S. A. 88: 2051-2054.
77. Harmsen, B. J., S. H. De Bruin, L. H. Janssen, J. F. Rodrigues de Miranda, and GA. Van Os. 1971. pK change of imidazole groups in bovine serum albumin due to the conformational change at neutral pH. Biochemistry. 10: 3217-3221.
78. Hawkins, D., R. N. Pinckard, I. P. Crawford, and R. S. Farr. 1969. Structural changes in human serum albumin induced by ingestion of acetylsalicylic acid. J. Clin. Invest. 48: 536-542.
79. He, X. M. and D. C. Carter. 1992. Atomic structure and chemistry of human serum albumin. Nature 358: 209-215.
80. Honoré, B. 1987. Protein binding studies with radiolabeled compounds containing radiochemical impurities. Equilibrium dialysis versus dialysis rate determination. Anal. Biochem. 162: 80-88.
81. Honoré, B. 1990. Conformational changes in human serum albumin induced by ligand binding. Pharmacol. Toxicol. 66 Suppl 2: 7-26.
82. Honoré, B. and R. Brodersen. 1984. Albumin binding of anti-inflammatory drugs. Utility of a site-oriented versus a stoichiometric analysis. Mol. Pharmacol. 25: 137-150.
83. Honoré, B. and R. Brodersen. 1988. Detection of carrier heterogeneity by rate of ligand dialysis: medium-chain fatty acid interaction with human serum albumin and competition with chloride. Anal. Biochem. 171: 55-66.
84. Honoré, B. and R. Brodersen. 1992. lonization of tyrosine residues in human serum albumin and in its complexes with bilirubin and laurate. Int. J. Pept. Protein Res. 39: 24-28.
85. Honoré, B. and A. O. Pedersen. 1989. Conformational changes in human serum albumin studied by fluorescence and absorption spectroscopy. Distance measurements as a function of pH and fatty acids. Biochem. J. 258: 199-204.
86. Honoré, B., H. Sato, and R. Brodersen. 1988. Cobinding of bilirubin and laurate to human serum albumin: spectroscopic characterization of stoichiometric complexes. Arch. Biochem. Biophys. 266: 189-196.
87. Hvidt, A. and K. Wallevik. 1972. Conformational changes in human serum albumin as revealed by hydrogen-deuterium exchange studies. J. Biol. Chem. 247: 1530-1535.
88. Iberg, N. and R. Fluckiger. 1986. Nonenzymatic glycosylation of albumin in vivo. Identification of multiple glycosylated sites. J. Biol. Chem. 261: 13542-13545.
89. Iyer, K. S., S. J. Lau, S. H. Laurie, and B. Sarkar. 1978. Synthesis of the native copper(II)-transport site of human serum albumin and its copper(II)-binding properties. Biochem. J. 169: 61-69.
90. Jacobsen, C. 1972. Chemical modification of the high-affinity bilirubin-binding site of human-serum albumin. Eur. J. Biochem. 27: 513-519.
91. Jacobsen, J. and R. Brodersen. 1983. Albumin-bilirubin binding mechanism. J. Biol. Chem. 258: 6319-6326.
92. Janssen, L. H., M. T. Van Wilgenburg, and J. Wilting. 1981. Human serum albumin as an allosteric two-state protein. Evidence from effects of calcium and warfarin on proton binding behaviour. Biochim. Biophys. Acta 669: 244-250.
93. Jarnerot, G., S. Andersen, E. Esbjorner, B. Sandstrom, and R. Brodersen. 1981. Albumin reserve for binding of bilirubin in maternal and cord serum under treatment with sulphasalazine. Scand. J. Gastroenterol. 16: 1049-1055.
94. Jin, Y. J., W. L. Li, and Q. R. Wang. 1991. Tb(III) as a fluorescent probe for the structure of bovine serum albumin. Biochem. Biophys. Res. Commun. 177: 474-479.
95. John, L. M. and J. W. McBain. 1948. The Hydrolysis of Soap Solutions. - II. The Solubilities of Higer Fatty Acids. J. Am. Oil Chem. Soc. 40-41.
96. Johnson, M. L. 1985. The analysis of ligand-binding data with experimental uncertainties in the independent variables. Anal. Biochem. 148: 471-478.
97. Klotz, I. M. 1945. The Application of the Law of Mass Action to Binding by Proteins. Interactions with Calcium. Arch. Biochem. 9: 109-117.
98. Klotz, I. M. and D. L. Hunston. 1975. Protein interactions with small molecules. Relationships between stoichiometric binding constants, site binding constants, and empirical binding parameters. J. Biol. Chem. 250: 3001-3009.
99. Klotz, I. M. and D. L. Hunston. 1979. Protein affinities for small molecules: conceptions and misconceptions. Arch. Biochem. Biophys. 193: 314-328.
100. Kober, A., Y. Olsson, and I. Sjoholm. 1980. Binding of drugs to human serum albumin. XIV. The theoretical basis for the interaction between phenytoin and valproate. Mol. Pharmacol. 18: 237-242.
101. Koh, S. W. and G. E. Means. 1979. Characterization of a small apolar anion binding site of human serum albumin. Arch. Biochem. Biophys. 192: 73-79.
102. Kragh-Hansen, U. 1981. Molecular aspects of ligand binding to serum albumin. Pharmacol. Rev. 33: 17-53.
103. Kragh-Hansen, U. 1985. Relations between high-affinity binding sites of markers for binding regions on human serum albumin. Biochem. J. 225: 629-638.
104. Kragh-Hansen, U. 1988. Evidence for a large and flexible region of human serum albumin possessing high affinity binding sites for salicylate, warfarin, and other ligands. Mol. Pharmacol. 34: 160-171.
105. Kragh-Hansen, U. 1990. Structure and ligand binding properties of human serum albumin. Dan. Med. Bull. 37: 57-84.
106. Kragh-Hansen, U., S. O. Brennan, M. Galliano, and O. Sugita. 1990. Binding of warfarin, salicylate, and diazepam to genetic variants of human serum albumin with known mutations. Mol. Pharmacol. 37: 238-242.
107. 2+ to natural mutants of human serum albumin and proalbumin. Biochem. J. 301: 217-223.
108. Kragh-Hansen, U., L. Minchiotti, S. O. Brennan, and O. Sugita. 1990. Hormone binding to natural mutants of human serum albumin. Eur. J. Biochem. 193: 169-174.
109. Kretsinger, R. H. and C. E. Nockolds. 1973. Carp muscle calcium-binding protein. II. Structure determination and general description. J. Biol. Chem. 248: 3313-3326.
110. Kurono, Y., T. Kondo, and K. Ikeda. 1983. Esterase-like activity of human serum albumin: enantioselectivity in the burst phase of reaction with p-nitrophenyl alpha-methoxyphenyl acetate. Arch. Biochem. Biophys. 227: 339-341.
111. Larsen, F. G., C. G. Larsen, S. Andersen, A. Nørgaard, H. E. Hansen, and R. Brodersen. 1986. Warfarin binding to plasma albumin, measured in patients and related to fatty acid concentrations. Eur. J. Clin. Invest. 16: 22-27.
112. Larsen, F. G., C. G. Larsen, P. Jakobsen, and R. Brodersen. 1985. Interaction of warfarin with human serum albumin. A stoichiometric description. Mol. Pharmacol. 27: 263-270.
113. Li, K. L., A. K. Thakur, and A. L. Kapoor. 1988. Structural requirements for binding of nonsteroidal anti-inflammatory drugs to human serum albumin. J. Pharm. Sci 77: 251-254.
114. Lind, K. E., U. Kragh-Hansen, and J. V. Møller. 1974. Protein binding of small molecules. V. Binding of bromphenol blue by chemical modifications of human serum albumin. Biochim. Biophys. Acta 371: 451-461.
115. Malaisse, W. J., F. Malaisse Lagae, A. Sener, and C. Hellerström. 1985. Participation of endogenous fatty acids in the secretory activity of the pancreatic B-cell. Biochem. J. 227: 995-1002.
116. McLean, F. C. and A. B. Hastings. 1934. A biological method for the estimation of calcium ion concentration. J. Biol. Chem. 107: 337-350.
117. McLean, F. C. and A. B. Hastings. 1935. The state of calcium in the fluids of the body. I. Conditions affecting the ionization of calcium. J. Biol. Chem. 108: 285-322.
118. McPhalen, C. A., N. C. Strynadka, and M. N. James. 1991. Calcium-binding sites in proteins: a structural perspective. Adv. Protein Chem. 42: 77-144.
119. Minghetti, P. P., D. E. Ruffner, W. J. Kuang, O. E. Dennison, J. W. Hawkins, W. G. Beattte, and A. Dugaiczyk. 1986. Molecular structure of the human albumin gene is revealed by nucleotide sequence within q 11-22 of chromosome 4. J. Biol. Chem. 261: 6747-6757.
120. Moran, J. B., F. J. Burczynski, R. F. Cheek, T. Bopp, and E. L. Forker. 1987. Protein binding of palmitate measured by transmembrane diffusion through polyethylene. Anal. Biochem. 167: 394-399.
121. Mukerjee, P. 1965. Dimerization of Anions of Long-chain Fatty Acids in Aqueous Solutions and the Hydrophobic Properties of the Acids. J. Phys. Chem. 69: 2821-2827.
122. Müller, W. and U. Wollert. 1976. Circular dichroism studies on the interaction of four structurally related long-acting sulfonamides with human and bovine serum albumin. Biochem. Pharmacol. 25: 1459-1464.
123. Mungall, D., Y. Y. Wong, R. L. Talbert, M. H. Crawford, J. Marshall, D. W. Hawkins, and T. M. Ludden. 1984. Plasma protein binding of warfarin: methodological considerations. J. Pharm. Sci 73: 1000-1001.
124. Nielsen, H., U. Kragh-Hansen, L. Minchiotti, M. Galliano, S. O. Brennan, A. L. Tarnoky, M. H. L. P Franco, F. M. Salzano, and O. Sugita. 1997. Effect of genetic variation on the fatty acid-binding properties of human serum albumin and proalbumin. Biochim. Biophys. Acta 1342: 191-204.
125. Nyrén, V. and E. Back. 1958. The lonization Constant, Solubility Product and Solubility of Lauric and Myristic Acid. Acta Chem. Scand. 12: 1305-1311.
126. O'Reilly, R. A. 1971. Interaction of several coumarin compounds with human and canine plasma albumin. Mol. Pharmacol. 7: 209-218.
127. Oida, T. 1986. Proton nuclear magnetic resonance study on the multimode interactions of human serum albumin with drug molecules. J. Biochem. Tokyo 100: 99-113.
128. Osborne, W. A. 1906. Intracellular coloidal salts. J. Physiol. 34: 84.
129. Otagiri, M., J. S. Fleitman, and J. H. Perrin. 1980. Investigations into the binding of phenprocoumon to albumin using fluorescence spectroscopy. J. Pharm. Pharmacol. 32: 478-482.
130. Otagiri, M. and J. H. Perrin. 1977. Circular dichroic investigations of the binding of salicylate and related compounds to human serum albumin. Biochem. Pharmacol. 26: 283-288.
131. Ozeki, Y., Y Kurono, T. Yotsuyanagi, and K. Ikeda. 1980. Effects of drug binding on the esterase activity of human serum albumin: inhibition modes and binding sites of anionic drugs. Chem. Pharm. Bull. Tokyo 28: 535-540.
132. 13C NMR study. J. Biol. Chem. 258: 9262-9269.
133. Patel, I. H. and R. H. Levy. 1979. Valproic acid binding to human serum albumin and determination of free fraction in the presence of anticon-vulsants and free fatty acids. Epilepsia 20: 85-90.
134. Patil, G. S., R. H. Matthews, and D. G. Cornwell. 1973. Kinetics of the processes of desorption from fatty acid monolayers. J. Lipid. Res. 14: 26-31.
135. Pedersen, A. O. and R. Brodersen. 1988. Myristic acid binding to human serum albumin investigated by dialytic exchange rate. J. Biol. Chem. 263: 10236-10239.
136. Pedersen, A. O., B. Honoré, and R. Brodersen. 1990. Thermodynamic parameters for binding of fatty acids to human serum albumin. Eur. J. Biochem. 190: 497-502.
137. Pedersen, A. O., B. Hust, S. Andersen, F. Nielsen, and R. Brodersen. 1986. Laurate binding to human serum albumin. Multiple binding equilibria investigated by a dialysis exchange method. Eur. J. Biochem. 154: 545-552.
138. Pedersen, A. O. and J. Jacobsen. 1980. Reactivity of the thiol group in human and bovine albumin at pH 3-9, as measured by exchange with 2,2'-dithiodipyridine. Eur. J. Biochem. 106: 291-295.
139. Pedersen, A. O., K. L. Mensberg, and U. Kragh-Hansen. 1995. Effects of ionic strength and pH on the binding of medium-chain fatty acids to human serum albumin. Eur. J. Biochem. 233: 395-405.
140. Pedersen, K. O. 1971. Binding of calcium to serum albumin. I. Stoichiometry and intrinsic association constant at physiological pH, ionic strength, and temperature. Scand. J. Clin. Lab. Invest. 28: 459-469.
141. Pedersen, K. O. 1972. Binding of calcium to serum albumin. IV. Effect of temperature and thermodynamics of calcium-albumin interaction. Scand. J. Clin. Lab. Invest. 30: 89-94.
142. Pedersen, K. O. 1972. Binding of calcium to serum albumin. II. Effect of pH via competitive hydrogen and calcium ion binding to the imidazole groups of albumin. Scand. J. Clin. Lab. Invest. 29: 75-83.
143. Perrin, J. H. and D. A. Nelson. 1972. Induced optical activity following the binding of warfarin, indomethacin, 4-hydroxycoumarin and salicylic acid to human serum albumin. Life. Sci. 11: 277-283.
144. Peters, T. J. and F. A. Blumenstock. 1967. Copper-binding properties of bovine serum albumin and its amino-terminal peptide fragment. J. Biol. Chem. 242: 1574-1578.
145. Peters, T. Jr. 1970. Serum Albumin. Adv. Clin. Chem. 13: 37-111.
146. Peters, T. Jr. 1975. Serum Albumin. In The Plasma Proteins. F.W. Putnam, editor. Academic Press, New York. 133-181.
147. Peters, T. Jr. 1985. Serum Albumin. Adv. Protein Chem. 37: 161-245.
148. Peters, T. Jr. 1996. All about Albumin. Biochemistry, Genetics, and Medical Applications. Academic Press, New York.
149. Peters, T. Jr. and R. C. Feldhoff. 1975. Fragments of bovine serum albumin produced by limited proteolysis. Isolation and characterization of tryptic fragments. Biochemistry. 14: 3384-3391.
150. Pinkerton, T. C. and K. A. Koeplinger. 1998. Determination of warfarin-human serum albumin protein binding parameters by an improved Hummel-Dreyer high-performance liquid Chromatographic method using internal surface reversed-phase columns. Anal. Chem. 62: 2114-2122.
151. Potter, B. J., D. Sorrentino, and P. D. Berk. 1989. Mechanism of Cellular Uptake of Free Fatty Acids. Annu. Rev. Nutr. 9: 253-270.
152. Ralston, A. W. and C. W. Hoerr. 1942. The Solubility of the Normal Saturated Fatty Acids. J. Org. Chem. 7: 546-555.
153. Reed, R. G. 1986. Location of long chain fatty acid-binding sites of bovine serum albumin by affinity labeling. J. Biol. Chem. 261: 15619-15624.
154. Reed, R. G., T. Gates, and T. Peters. 1975. Albumin immobilized on agarose as a tool for measuring ligand binding of proteins or peptides. Anal. Biochem. 69: 361-371.
155. Reich, J.G. 1981. In Kinetic Data Analysis. L. Endreyi, editor. Plenum Press, New York. 39-50.
156. Richieri, G. V., A. Anel, and A. M. Kleinfeld. 1993. Interactions of long-chain fatty acids and albumin: determination of free fatty acid levels using the fluorescent probe ADIFAB. Biochemistry. 32: 7574-7580.
157. Richieri, G. V., R. T. Ogata, and A. M. Kleinfeld. 1992. A fluorescently labeled intestinal fatty acid binding protein. Interactions with fatty acids and its use in monitoring free fatty acids. J. Biol. Chem. 267: 23495-23501.
158. Rietbrock, N., G. Menke, G. Reuter, A. Lassmann, and R. Schmeidl. 1985. Influence of palmitate and oleate on the binding of warfarin to human serum albumin: stopped-flow studies. J. Clin. Chem. Clin. Biochem. 23: 719-723.
159. Rippie, E. G. 1976. Thermodynamics of fatty acid anion displacement of warfarin and phenylbutazone from human albumin. Biochem. Pharmacol. 25: 1215-1216.
160. Saber, M. A., P. Stockbauer, L. Moravek, and B. Meloun. 1977. Disulphide Bonds in Human Serum Albumin. Collection Czechoslov. Chem. Commun. 42: 564-579.
161. Saifer, A. and L. Goldman. 1961. The Free Fatty Acids Bound to Human Serum Albumin. J. Lipid. Res. 2: 268-270.
162. Scatchard, G. 1948. The Attractions of Proteins for Small Molecules and Ions. Ann. N. Y. Acad. Sci. 660-672.
163. Scheider, W., H. M. Dintzis, and J. L. Oncley. 1976. Changes in the electric dipole vector of human serum albumin due to complexing with fatty acids. Biophys. J. 16: 417-431.
164. Schwieterman, W., D. Sorrentino, B. J. Potter, J. Rand, C. L. Kiang, D. Stump, and P. D. Berk. 1988. Uptake of oleate by isolated rat adipocytes is mediated by a 40-kDa plasma membrane fatty acid binding protein closely related to that in liver and gut. Proc. Natl. Acad. Sci. U. S. A. 85: 359-363.
165. Sellers, E. M. and J. Kock-Weser. 1976. Interaction of Warfarin Stereoisomers with Human Albumin. Pharmacol. Res. Commun. 7: 331-336.
166. Serlin, M. J. and A. M. Breckenridge. 1983. Drug interactions with warfarin. Drugs 25: 610-620.
167. Shaklai, N., R. L. Garlick, and H. F. Bunn. 1984. Nonenzymatic glycosylation of human serum albumin alters its conformation and function. J. Biol. Chem. 259: 3812-3817.
168. Simpson, R. B., J. D. Ashbrook, E. C. Santos, and A. A. Spector. 1974. Partition of fatty acids. J. Lipid. Res. 15: 415-422.
169. Smith, R. and C. Tanford. 1972. The critical micelle concentration of L-dipalmitoylphosphatidylcholine in water and water-methanol solutions. J. Mol. Biol. 67: 75-83.
170. Sollenne, N. P. and G. E. Means. 1979. Characterization of a specific drug binding site of human serum albumin. Mol. Pharmacol. 15: 754-757.
171. 14C to human albumin. Biochem. Pharmacol. 16: 1219-1226.
172. 14C from human albumin by various drugs and fatty acids. Biochem. Pharmacol. 17: 143-151.
173. Sorrentino, D., D. Stump, B. J. Potter, R. B. Robinson, R. White, C. L. Kiang, and P. D. Berk. 1988. Oleate uptake by cardiac myocytes is carrier mediated and involves a 40-kD plasma membrane fatty acid binding protein similar to that in liver, adipose tissue, and gut. J. Clin. Invest. 82: 928-935.
174. Spector, A. A. 1975. Fatty acid binding to plasma albumin. J. Lipid. Res. 16: 165-179.
175. Spector, A. A. 1986. Structure and lipid binding properties of serum albumin. Methods Enzymol. 128: 320-339.
176. Spector, A.A. and J.E. Fletcher. 1978. Transport of fatty acid in the circulation. In Disturbances in Lipid and Lipoprotein Metabolism. J.M. Dietschy, A.M. Gotto, and J.A. Ontko, editors. Waverley Press, Baltimore, Maryland. 229-250.
177. Spector, A. A., K. John, and J. E. Fletcher. 1969. Binding of long-chain fatty acids to bovine serum albumin. J. Lipid. Res. 10: 56-67.
178. Stamler, J. S., D. I. Simon, J. A. Osborne, M. E. Mullins, O. Jaraki, T. Michel, D. J. Singel, and J. Loscalzo. 1992. S-nitrosylation of proteins with nitric oxide: synthesis and characterization of biologically active compounds. Proc. Natl. Acad. Sci. U. S. A. 89: 444-448.
179. Stremmel, W., G. Strohmeyer, and P. D. Berk. 1986. Hepatocellular uptake of oleate is energy dependent, sodium linked, and inhibited by an antibody to a hepatocyte plasma membrane fatty acid binding protein. Proc. Natl. Acad. Sci. U. S. A. 83: 3584-3588.
180. Sudlow, G., D. J. Birkett, and D. N. Wade. 1975. Spectroscopic techniques in the study of protein binding. A fluorescence technique for the evaluation of the albumin binding and displacement of warfarin and warfarin-alcohol. Clin. Exp. Pharmacol Physiol. 2: 129-140.
181. Sudlow, G., D. J. Birkett, and D. N. Wade. 1975. The characterization of two specific drug binding sites on human serum albumin. Mol. Pharmacol. 11: 824-832.
182. Sudlow, G., D. J. Birkett, and D. N. Wade. 1976. Further characterization of specific drug binding sites on human serum albumin. Mol. Pharmacol. 12: 1052-1061.
183. Svenson, A., E. Holmer, and L. O. Andersson. 1974. A new method for the measurement of dissociation rates for complexes between small ligands and proteins as applied to the palmitate and bilirubin complexes with serum albumin. Biochim. Biophys. Acta 342: 54-59.
184. Takabayashi, K., T. Imada, Y. Saito, and Y. Inada. 1983. Coupling between fatty acid binding and sulfhydryl oxidation in bovine serum albumin. Eur. J. Biochem. 136: 291-295.
185. Thiessen, H., J. Jacobsen, and R. Brodersen. 1972. Displacement of albumin-bound bilirubin by fatty acids. Acta Paediatr. Scand. 61: 285-288.
186. Trimble, M. E. 1990. Renal palmitate transport: possible sites for interaction with a plasma membrane fatty acid-binding protein. Mol. Cell. Biochem. 98: 201-207.
187. Trimble, M. E. 1993. Palmitate transport by rat renal basolateral membrane vesicles in the presence of albumin. J. Am. Soc. Nephrol. 3: 1920-1929.
188. Vallner, J. J. 1977. Binding of drugs by albumin and plasma protein. J. Pharm. Sci. 66: 447-465.
189. Van Holde, K. E. 1971. Physical Biochemistry. Prince-Hall Inc., Englewood Cliffs, New Jersey.
190. Vorum, H. 1993. Fatty acid interaction with human serum albumin. Relation to diabetes, obesity, valproat-treatment, and anticoagulant therapy in surgery. Published by the author, Aarhus. (Ph.D.-thesis).
191. 2+-binding activity. Biochim. Biophys. Acta. 1386: 121-131.
192. Vorum, H., P. Madsen, H. H. Rasmussen, M. Etzerodt, I. Svendsen, J. E. Celis, and B. Honoré. 1996. Expression and divalent cation binding properties of the novel chemotactic inflammatory protein psoriasin. Electrophoresis 17: 1787-1796.
193. Walker, J. E. 1976. Lysine residue 199 of human serum albumin is modified by acetylsalicyclic acid. FEBS Lett. 66: 173-175.
194. Watanabe, S. and T. Saito. 1992. Conformational effects in the interaction of phenylbutazone with albumin studied by circular dichroism. Biochem. Pharmacol. 43: 931-935.
195. Weber, G. 1975. Energetics of ligand binding to proteins. Adv. Protein Chem. 29: 1-83.
196. Weber, G. and S. R. Anderson. 1965. Multiplicity of Binding. Range of Validity and Practical Test of Adair's Equation. Biochemistry. 4: 1942-1947.
197. Weisiger, R. A. and W. L. Ma. 1987. Uptake of oleate from albumin solutions by rat liver. Failure to detect catalysis of the dissociation of oleate from albumin by an albumin receptor. J. Clin. Invest. 79: 1070-1077.
198. West, B. D., S. Preis, C. H. Schroeder, and K. P. Link. 1961. Studies on the 4-hydroxycoumarins. XVII. The resolution and absolute configuration of warfarin. J. Am. Chem. Soc. 83: 2676-2679.
199. Wilding, G., R. C. Feldhoff, and E. S. Vesell. 1977. Concentration-dependent effects of fatty acids on warfarin binding to albumin. Biochem. Pharmacol. 26: 1143-1146.
200. Wosilait, W. D. and M. P. Ryan. 1979. The effects of oleic acid, tolbutamide, and oxyphenbutazone on the binding of warfarin by human serum albumin. Res. Commun. Chem. Pathol. Pharmacol. 25: 577-584.
201. Wosilait, W. D. and M. P. Ryan. 1980. Multiple competitive displacement interactions involving human serum albumin, anticoagulants, oleic acid and various drugs. Gen. Pharmacol. 11: 387-394.
202. Yacobi, A. and G. Levy. 1975. Effect of plasma protein binding on the anticoagulant action of warfarin. Res. Commun. Chem. Pathol. Pharmacol. 12: 405-408.
203. Yacobi, A., J. A. Udall, and G. Levy. 1976. Serum protein binding as a determinant of warfarin body clearance and anticoagulant effect. Clin. Pharmacol. Ther. 19: 522-528.
204. Yvon, M., P. Anglade, and J. M. Wal. 1990. Identification of the binding sites of benzyl penicilloyl, the allergenic metabolite of penicillin, on the serum albumin molecule. FEBS Lett. 263: 237-240.
205. Zaloga, G. P., S. Willey, P. Tomasic, and B. Chernow. 1987. Free fatty acids alter calcium binding: a cause for misinterpretation of serum calcium values and hypocalcemia in critical illness. J. Clin. Endocrinol. Metab. 64: 1010-1014.